1616342-45-0 Usage
Uses
Used in Pharmaceutical and Medicinal Applications:
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid is utilized as a pharmaceutical and medicinal agent due to its potential to interact with biological systems. Its specific molecular structure allows it to target and modulate various biological pathways and processes, offering a promising avenue for the development of new therapeutics.
Used in Organic Chemistry Research:
In the field of organic chemistry, (2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid serves as a subject of study for understanding the synthesis, properties, and reactivity of complex organic molecules. Its intricate structure provides a platform for exploring novel synthetic routes and reaction mechanisms, contributing to the advancement of organic chemistry knowledge.
Used in Drug Development:
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid is employed in drug development as a candidate molecule for the creation of new pharmaceuticals. Its unique structural elements may offer novel modes of action, selectivity, and potency, making it a valuable asset in the search for innovative treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1616342-45-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,6,3,4 and 2 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1616342-45:
(9*1)+(8*6)+(7*1)+(6*6)+(5*3)+(4*4)+(3*2)+(2*4)+(1*5)=150
150 % 10 = 0
So 1616342-45-0 is a valid CAS Registry Number.
1616342-45-0Relevant academic research and scientific papers
CONTINUES FLOW PROCESS FOR THE PREPARATION OF ACTIVE PHARMACEUTICAL INGREDIENTS - POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVES AND INTERMEDIATES THEREOF
-
, (2019/09/04)
The present invention discloses continues flow process for the preparation of polycyclic carbamoyl pyridone derivatives and intermediates thereof. In particular, the present invention discloses a process for the preparation of intermediate. Formule (V).
PROCESS FOR THE PREPARATION OF BICTEGRAVIR AND INTERMEDIATE THEREOF
-
Page/Page column 16; 17; 18, (2019/01/07)
The present invention provides processes and intermediates for the synthesis of bictegravir and its pharmaceutical salt.
POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
-
, (2014/07/08)
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Y1, Y2, Ζ1 and Z4 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
